94 related articles for article (PubMed ID: 19883743)
1. Nonlinear absorption of methylprednisolone by absorptive and secretory transporters.
Tomita M; Watanabe A; Fujinaga I; Yamakawa T; Hayashi M
Int J Pharm; 2010 Mar; 387(1-2):1-6. PubMed ID: 19883743
[TBL] [Abstract][Full Text] [Related]
2. Nonlinear intestinal absorption of 5-hydroxytryptamine receptor antagonist caused by absorptive and secretory transporters.
Tamai I; Saheki A; Saitoh R; Sai Y; Yamada I; Tsuji A
J Pharmacol Exp Ther; 1997 Oct; 283(1):108-15. PubMed ID: 9336314
[TBL] [Abstract][Full Text] [Related]
3. Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies.
Shen Q; Li W; Lin Y; Katsumi H; Okada N; Sakane T; Fujita T; Yamamoto A
J Pharm Pharmacol; 2008 Dec; 60(12):1633-41. PubMed ID: 19000368
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
[TBL] [Abstract][Full Text] [Related]
5. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds.
Yumoto R; Murakami T; Nakamoto Y; Hasegawa R; Nagai J; Takano M
J Pharmacol Exp Ther; 1999 Apr; 289(1):149-55. PubMed ID: 10086998
[TBL] [Abstract][Full Text] [Related]
6. Relative contribution of absorptive and secretory transporters to the intestinal absorption of fexofenadine in rats.
Ujie K; Oda M; Kobayashi M; Saitoh H
Int J Pharm; 2008 Sep; 361(1-2):7-11. PubMed ID: 18572335
[TBL] [Abstract][Full Text] [Related]
7. Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line Caco-2 and everted gut sacs.
Sha X; Fang X
Int J Pharm; 2004 Mar; 272(1-2):161-71. PubMed ID: 15019079
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective and multiple carrier-mediated transport of cetirizine across Caco-2 cell monolayers with potential drug interaction.
He Y; Liu Y; Zeng S
Chirality; 2010 Jul; 22(7):684-92. PubMed ID: 20014242
[TBL] [Abstract][Full Text] [Related]
9. Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies.
Shen Q; Lin Y; Handa T; Doi M; Sugie M; Wakayama K; Okada N; Fujita T; Yamamoto A
Int J Pharm; 2006 Apr; 313(1-2):49-56. PubMed ID: 16500056
[TBL] [Abstract][Full Text] [Related]
10. Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2.
Yu L; Zeng S
J Pharm Pharmacol; 2007 May; 59(5):655-60. PubMed ID: 17524230
[TBL] [Abstract][Full Text] [Related]
11. Nonlinear intestinal absorption of (1-->3)-beta-D-glucan caused by absorptive and secretory transporting system.
Tomita M; Miwa M; Ouchi S; Oda T; Aketagawa J; Goto Y; Hayashi M
Biol Pharm Bull; 2009 Jul; 32(7):1295-7. PubMed ID: 19571402
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of P-glycoprotein expression in small intestine under chronic serotonin-depleted conditions in rats.
Hiraoka H; Kimura N; Furukawa Y; Ogawara K; Kimura T; Higaki K
J Pharmacol Exp Ther; 2005 Jan; 312(1):248-55. PubMed ID: 15466248
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective transport and uptake of propranolol across human intestinal Caco-2 cell monolayers.
Wang Y; Cao J; Wang X; Zeng S
Chirality; 2010 Mar; 22(3):361-8. PubMed ID: 19575464
[TBL] [Abstract][Full Text] [Related]
14. Fluorescein transport properties across artificial lipid membranes, Caco-2 cell monolayers and rat jejunum.
Berginc K; Zakelj S; Levstik L; Ursic D; Kristl A
Eur J Pharm Biopharm; 2007 May; 66(2):281-5. PubMed ID: 17129714
[TBL] [Abstract][Full Text] [Related]
15. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
16. Sulfasalazine transport in in-vitro, ex-vivo and in-vivo absorption models: contribution of efflux carriers and their modulation by co-administration of synthetic nature-identical fruit extracts.
Mols R; Deferme S; Augustijns P
J Pharm Pharmacol; 2005 Dec; 57(12):1565-73. PubMed ID: 16354400
[TBL] [Abstract][Full Text] [Related]
17. Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line caco-2.
Yamaguchi H; Yano I; Hashimoto Y; Inui KI
J Pharmacol Exp Ther; 2000 Oct; 295(1):360-6. PubMed ID: 10992002
[TBL] [Abstract][Full Text] [Related]
18. Transport characteristics of rutin deca (H-) sulfonate sodium across Caco-2 cell monolayers.
He Y; Zeng S
J Pharm Pharmacol; 2005 Oct; 57(10):1297-303. PubMed ID: 16259758
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound.
Spahn-Langguth H; Baktir G; Radschuweit A; Okyar A; Terhaag B; Ader P; Hanafy A; Langguth P
Int J Clin Pharmacol Ther; 1998 Jan; 36(1):16-24. PubMed ID: 9476144
[TBL] [Abstract][Full Text] [Related]
20. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
Panchagnula R; Bansal T; Varma MV; Kaul CL
Pharmazie; 2005 Dec; 60(12):922-7. PubMed ID: 16398269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]